Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other Operating Expenses: 2013-2018

Historic Other Operating Expenses for Rocket Pharmaceuticals (RCKT) over the last 4 years, with Dec 2018 value amounting to -$78.2 million.

  • Rocket Pharmaceuticals' Other Operating Expenses was N/A to $3.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$74.8 million, marking a year-over-year change of. This contributed to the annual value of -$78.2 million for FY2018, which is 118.81% down from last year.
  • As of FY2018, Rocket Pharmaceuticals' Other Operating Expenses stood at -$78.2 million, which was down 118.81% from -$35.8 million recorded in FY2017.
  • Rocket Pharmaceuticals' Other Operating Expenses' 5-year high stood at -$15.4 million during FY2014, with a 5-year trough of -$78.2 million in FY2018.
  • Over the past 2 years, Rocket Pharmaceuticals' median Other Operating Expenses value was -$57.0 million (recorded in 2017), while the average stood at -$57.0 million.
  • Data for Rocket Pharmaceuticals' Other Operating Expenses shows a maximum YoY slumped of 118.81% (in 2018) over the last 5 years.
  • Yearly analysis of 3 years shows Rocket Pharmaceuticals' Other Operating Expenses stood at -$15.4 million in 2014, then reached -$35.8 million in 2017, then tumbled by 118.81% to -$78.2 million in 2018.